12/3
12:05 pm
blte
Belite Bio (NASDAQ:BLTE) had its "buy" rating reaffirmed by analysts at Benchmark Co..
Low
Report
Belite Bio (NASDAQ:BLTE) had its "buy" rating reaffirmed by analysts at Benchmark Co..
12/3
12:05 pm
blte
Belite Bio (NASDAQ:BLTE) had its "buy" rating reaffirmed by analysts at Benchmark Co..
Low
Report
Belite Bio (NASDAQ:BLTE) had its "buy" rating reaffirmed by analysts at Benchmark Co..
12/3
07:57 am
blte
Belite Bio (NASDAQ:BLTE) was upgraded by analysts at Mizuho from a "hold" rating to a "strong-buy" rating.
Low
Report
Belite Bio (NASDAQ:BLTE) was upgraded by analysts at Mizuho from a "hold" rating to a "strong-buy" rating.
12/3
07:57 am
blte
Belite Bio (NASDAQ:BLTE) was upgraded by analysts at Mizuho from a "hold" rating to a "strong-buy" rating.
Low
Report
Belite Bio (NASDAQ:BLTE) was upgraded by analysts at Mizuho from a "hold" rating to a "strong-buy" rating.
12/2
10:04 am
blte
Rating for BLTE
Low
Report
Rating for BLTE
12/2
10:04 am
blte
Rating for BLTE
Low
Report
Rating for BLTE
12/2
05:11 am
blte
Belite Bio upgraded to Outperform from Neutral at Mizuho
Medium
Report
Belite Bio upgraded to Outperform from Neutral at Mizuho
12/2
05:11 am
blte
Belite Bio upgraded to Outperform from Neutral at Mizuho
Medium
Report
Belite Bio upgraded to Outperform from Neutral at Mizuho
12/1
12:10 pm
blte
Belite Bio (NASDAQ:BLTE) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Belite Bio (NASDAQ:BLTE) had its "buy" rating reaffirmed by analysts at HC Wainwright.
11/24
09:23 am
blte
Belite Bio (NASDAQ:BLTE) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $154.00 price target on the stock.
Medium
Report
Belite Bio (NASDAQ:BLTE) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $154.00 price target on the stock.
11/24
09:19 am
blte
Rating for BLTE
Medium
Report
Rating for BLTE
11/20
11:10 am
blte
Rating for BLTE
Medium
Report
Rating for BLTE
11/20
11:10 am
blte
Rating for BLTE
Medium
Report
Rating for BLTE
11/20
08:43 am
blte
Belite Bio (NASDAQ:BLTE) is now covered by analysts at Mizuho. They set a "neutral" rating and a $105.00 price target on the stock.
Medium
Report
Belite Bio (NASDAQ:BLTE) is now covered by analysts at Mizuho. They set a "neutral" rating and a $105.00 price target on the stock.
11/20
08:43 am
blte
Belite Bio (NASDAQ:BLTE) is now covered by analysts at Mizuho. They set a "neutral" rating and a $105.00 price target on the stock.
Medium
Report
Belite Bio (NASDAQ:BLTE) is now covered by analysts at Mizuho. They set a "neutral" rating and a $105.00 price target on the stock.
11/20
05:44 am
blte
Belite Bio initiated with a Neutral at Mizuho
Medium
Report
Belite Bio initiated with a Neutral at Mizuho
11/20
05:44 am
blte
Belite Bio initiated with a Neutral at Mizuho
Medium
Report
Belite Bio initiated with a Neutral at Mizuho
10/31
10:06 am
blte
Rating for BLTE
Medium
Report
Rating for BLTE
10/31
10:06 am
blte
Rating for BLTE
Medium
Report
Rating for BLTE